Bridgeway Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267K | Buy |
|
|||||
|
2025
Q1 | $131K | Hold |
|
|||||
|
2024
Q4 | $221K | Sell |
|
|||||
|
2024
Q3 | $672K | Hold |
|
|||||
|
2024
Q2 | $232K | Sell |
|
|||||
|
2024
Q1 | $399K | Buy |
|
|||||
|
2023
Q4 | $263K | Hold |
|
|||||
|
2023
Q3 | $218K | Buy |
|
|||||
|
2023
Q2 | $250K | Sell |
|
|||||
|
2023
Q1 | $145K | Hold |
|
|||||
|
2022
Q4 | $135K | Hold |
|
|||||
|
2022
Q3 | $130K | Hold |
|
|||||
|
2022
Q2 | $158K | Hold |
|
|||||
|
2022
Q1 | $261K | Sell |
|
|||||
|
2021
Q4 | $541K | Buy |
|
|||||
|
2021
Q3 | $771K | Sell |
|
|||||
|
2021
Q2 | $559K | Buy |
|
|||||
|
2021
Q1 | $629K | Buy |
|
|||||
|
2020
Q4 | $476K | Hold |
|
|||||
|
2020
Q3 | $536K | Hold |
|
|||||
|
2020
Q2 | $364K | Hold |
|
|||||
|
2020
Q1 | $282K | Hold |
|
|||||
|
2019
Q4 | $727K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $358K | Buy |
|
|||||
|
2018
Q4 | $292K | Sell |
|
|||||
|
2018
Q3 | $897K | Buy |
|
|||||
|
2018
Q2 | $933K | Hold |
|
|||||
|
2018
Q1 | $980K | Hold |
|
|||||
|
2017
Q4 | $881K | Hold |
|
|||||
|
2017
Q3 | $1.35M | Buy |
|